Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 235

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation

Zhou, Ge, Wang, Jiping, Zhao, Mei, Xie, Tong-Xin, Tanaka, Noriaki, Sano, Daisuke, Patel, Ameeta A., Ward, Alexandra M., Sandulache, Vlad C., Jasser, Samar A., Skinner, Heath D., Fitzgerald, Alison Lea, Osman, Abdullah A., Wei, Yongkun, Xia, Xuefeng, Songyang, Zhou, Mills, Gordon B., Hung, Mien-Chie, Caulin, Carlos, Liang, Jiyong, Myers, Jeffrey N.·2014·Molecular Cell
DOI 10.1016/j.molcel.2014.04.024
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2014.04.024

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 36

  1. Acin, 2011, Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras, J. Pathol., 225, 479, 10.1002/path.2971 · DOI
  2. Agrawal, 2011, Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1, Science, 333, 1154, 10.1126/science.1206923 · DOI · Paper page
  3. Berkers, 2013, Metabolic regulation by p53 family members, Cell Metab., 18, 617, 10.1016/j.cmet.2013.06.019 · DOI · Paper page
  4. Bertout, 2009, Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model, Cancer Res., 69, 3213, 10.1158/0008-5472.CAN-08-4223 · DOI
  5. DeBerardinis, 2012, Cellular metabolism and disease: what do metabolic outliers teach us?, Cell, 148, 1132, 10.1016/j.cell.2012.02.032 · DOI · Paper page
  6. Esfandiari, 2007, S-adenosylmethionine attenuates hepatic lipid synthesis in micropigs fed ethanol with a folate-deficient diet, Alcohol. Clin. Exp. Res., 31, 1231, 10.1111/j.1530-0277.2007.00407.x · DOI
  7. Faubert, 2013, AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo, Cell Metab., 17, 113, 10.1016/j.cmet.2012.12.001 · DOI · Paper page
  8. Feng, 2010, The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein, Trends Cell Biol., 20, 427, 10.1016/j.tcb.2010.03.004 · DOI · Paper page
  9. Fogarty, 2010, Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer, Biochim. Biophys. Acta, 1804, 581, 10.1016/j.bbapap.2009.09.012 · DOI · Paper page
  10. Freed-Pastor, 2012, Mutant p53: one name, many proteins, Genes Dev., 26, 1268, 10.1101/gad.190678.112 · DOI · Paper page
  11. Freed-Pastor, 2012, Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway, Cell, 148, 244, 10.1016/j.cell.2011.12.017 · DOI · Paper page
  12. Goldstein, 2012, Regulation of lipid metabolism by p53—fighting two villains with one sword, Trends Endocrinol. Metab., 23, 567, 10.1016/j.tem.2012.06.007 · DOI
  13. Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  14. Hardie, 2002, Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase, Biochem. Soc. Trans., 30, 1064, 10.1042/bst0301064 · DOI · Paper page
  15. Hawley, 1996, Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase, J. Biol. Chem., 271, 27879, 10.1074/jbc.271.44.27879 · DOI · Paper page
  16. He, 2014, AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity, Mol. Cell. Biol., 34, 148, 10.1128/MCB.00670-13 · DOI
  17. Jones, 2005, AMP-activated protein kinase induces a p53-dependent metabolic checkpoint, Mol. Cell, 18, 283, 10.1016/j.molcel.2005.03.027 · DOI · Paper page
  18. Kamat, 2007, Mutant p53 facilitates pro-angiogenic, hyperproliferative phenotype in response to chronic relative hypoxia, Cancer Lett., 249, 209, 10.1016/j.canlet.2006.08.017 · DOI
  19. Kodiha, 2007, Localization of AMP kinase is regulated by stress, cell density, and signaling through the MEK→ERK1/2 pathway, Am. J. Physiol. Cell Physiol., 293, C1427, 10.1152/ajpcell.00176.2007 · DOI
  20. Lang, 2004, Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome, Cell, 119, 861, 10.1016/j.cell.2004.11.006 · DOI · Paper page
  21. Lee, 2012, AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells, Cancer Res., 72, 4394, 10.1158/0008-5472.CAN-12-0429 · DOI · Paper page
  22. Li, 2007, Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?, Oncogene, 26, 2220, 10.1038/sj.onc.1210311 · DOI · Paper page
  23. Li, 2011, AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice, Cell Metab., 13, 376, 10.1016/j.cmet.2011.03.009 · DOI · Paper page
  24. Luo, 2010, AMPK as a metabolic tumor suppressor: control of metabolism and cell growth, Future Oncol., 6, 457, 10.2217/fon.09.174 · DOI · Paper page
  25. Morselli, 2008, Mutant p53 protein localized in the cytoplasm inhibits autophagy, Cell Cycle, 7, 3056, 10.4161/cc.7.19.6751 · DOI · Paper page
  26. Muller, 2013, p53 mutations in cancer, Nat. Cell Biol., 15, 2, 10.1038/ncb2641 · DOI · Paper page
  27. Nicholls, 2010, Bioenergetic profile experiment using C2C12 myoblast cells, J. Vis. Exp, 10.3791/2511 · DOI · Paper page
  28. Okoshi, 2008, Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress, J. Biol. Chem., 283, 3979, 10.1074/jbc.M705232200 · DOI · Paper page
  29. Oren, 2010, Mutant p53 gain-of-function in cancer, Cold Spring Harb. Perspect. Biol., 2, a001107, 10.1101/cshperspect.a001107 · DOI · Paper page
  30. Sano, 2011, Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer, Clin. Cancer Res., 17, 6658, 10.1158/1078-0432.CCR-11-0046 · DOI
  31. Solomon, 2012, Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature, J. Cell Sci., 125, 3144
  32. Stommel, 1999, A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking, EMBO J., 18, 1660, 10.1093/emboj/18.6.1660 · DOI · Paper page
  33. Stransky, 2011, The mutational landscape of head and neck squamous cell carcinoma, Science, 333, 1157, 10.1126/science.1208130 · DOI · Paper page
  34. Su, 2012, TAp63 is a master transcriptional regulator of lipid and glucose metabolism, Cell Metab., 16, 511, 10.1016/j.cmet.2012.09.006 · DOI
  35. Tsou, 2011, A fluorescent reporter of AMPK activity and cellular energy stress, Cell Metab., 13, 476, 10.1016/j.cmet.2011.03.006 · DOI · Paper page
  36. Xu, 2011, Gain of function of mutant p53 by coaggregation with multiple tumor suppressors, Nat. Chem. Biol., 7, 285, 10.1038/nchembio.546 · DOI · Paper page

Cited by

See all 235

Metadata

Authors
Zhou, G., Wang, J., Zhao, M., Xie, T.-X., Tanaka, N., Sano, D., Patel, A. A., Ward, A. M., Sandulache, V. C., Jasser, S. A., Skinner, H. D., Fitzgerald, A. L., Osman, A. A., Wei, Y., Xia, X., Songyang, Z., Mills, G. B., Hung, M.-C., Caulin, C., Liang, J., & Myers, J. N.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2014-06
Volume
54
Issue
6
Pages
960-974
ISSN
1097-2765
DOI
10.1016/j.molcel.2014.04.024
Cited by
235
References
11
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.